Trial of the novel peroral anti-tumor treatment in patients with solid tumors

What you commit to

• Study type: Interventional · Phase 1
• Planned participants: 30
• 1 site in 1 country
• Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of EU CTIS (euclinicaltrials.eu). It describes the study design.

AI-kivonat: who the study is looking for

Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults with advanced solid tumors who have no standard treatment left, or for whom standard treatment has failed. It tests a new treatment taken by mouth.

Age

18 years or older

Sex

All sexes can join.

Disease stage

Metastatic or locally advanced solid tumors with no standard therapy, or where standard therapy has failed. Tumor types named: lung, head and neck, colon, stomach, esophagus, breast, ovary and/or fallopian tube, or primary peritoneal high-grade serous carcinoma.

Earlier treatment

Standard therapy must have failed or must not exist.

Read by machine on 9 Nov 2026.

Sites (1)

Sites in registry order. Save your city in your profile to sort them by distance.

Are you the coordinator? Confirm the details